Published on Boston Magazine Web Site | September 11, 2015
In our data-obsessed culture, we use technology to track everything from the steps we take to how well we sleep at night. Why not use the same principle to keep chronic disease under control?
That’s the thinking behind a new technology called Dario, a blood sugar monitoring device—complete with lancet and testing strips—that attaches to smartphones. The device syncs the data from each test to both the user’s phone and the cloud, allowing people with diabetes to not only accurately test their blood sugar, but gain insight into how their daily activities and diet choices impact test results over time.
“You can use this to track your disease, manage yourself to stay in range, and always have that data available for a caregiver, for a physician, or even for a case manager at an insurance company,” says Todd Durniak, a Boson-based entrepreneur and the executive vice president of Dario’s parent company, LabStyle Innovations.
Already on sale in Canada, Australia, and New Zealand, Dario is currently awaiting FDA clearance to be sold in the United States. Durniak says he hopes and expects to gain approval by the end of the year. “It’s not a question of if for us, it’s a question of when,” he says, adding that the cost would be on-par with existing glucose testing methods when it hits the market.
Durniak says Dario is all part of a growing movement toward digitizing health and embracing data. “You have an insight into a daily treatment regimen, whether it’s weight control or diabetes management or managing heart disease,” he says of bringing data to healthcare. “If someone has to be on a treatment regime, it helps them stay on track, and it helps the people that are coaching them and working with them see if they’re on track.”
But even beyond the implications for an individual’s health, Durniak says Dario could provide trend information that could someday lead to better diabetes treatments.
“It allows you to really have a high-resolution view of how that person is living their day with diabetes,” he says. “Then you can also amplify that across people very easily if they’re all using the device. That kind of data and power and resolution can lead to insight, and that’s what we hope this helps accomplish.”